GREGG/KENNEDY COMPROMISE ON FDA DRUG/DEVICE EXPORT REFORM BILL PASSES SENATE LABOR COMMITTEE BY 16-0 VOTE; MEASURE LISTS SPECIFIC COUNTRIES
A compromise FDA drug/device export bill sponsored by Sens. Gregg (R-N.H.) and Kennedy (D-Mass.), the "FDA Export Reform & Enhancement Act of 1995" (S 593), was approved unanimously by the 16-member Labor & Human Resources Committee during an Aug. 2 mark-up. The compromise bill lists specific countries to which unapproved drugs and devices could be exported without FDA export approval.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth